Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04459455 · ClinicalTrials.gov registry record · NA
Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic
A NA study of Anxiety, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT04459455: Completed NA study of Anxiety, sponsored by Stony Brook University.
NCT04459455 is a NA study of Anxiety that has completed, run by Stony Brook University. The registered enrollment target is 500 participants, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04459455, a NA study of Anxiety, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to test whether an online, self-administered SSI designed to strengthen perceived control over anxiety in the context of the COVID-19 pandemic (Contain COVID Anxiety) increases perceived control over anxiety more than a placebo, hand-washing-plan SSI (Remain COVID Free) in a weighted-probability sample of the United States (N = 500).
Primary Outcome
ACQ is a 30-item questionnaire that measures an individual's level of agreement with a set of beliefs. Each item is scored on a scale from 0 (strongly disagree) to 5 (strongly agree) based on how much the statement is typical of the individual. The questionnaire measures domains of emotion control, threat control, and stress control, but only the emotion control scale (4 questions) will be used for the purposes of this study.
Conditions Studied
Interventions
- BEHAVIORAL Contain COVID Anxiety SSI
- BEHAVIORAL Remain COVID Free SSI
Study Locations (1)
New York
- Stony Brook University - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-08-19 |
| Est. Completion | 2020-10-15 |
| Phase | NA |
What the finished NCT04459455 record still lists
NCT04459455 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Contain COVID Anxiety SSI is the first listed.
NCT04459455 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04459455 about?
NCT04459455 is a clinical study titled "Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic". The goal of this study is to test whether an online, self-administered SSI designed to strengthen perceived control over anxiety in the context of the COVID-19 pandemic (Contain COVID Anxiety) increases perceived control over anxiety more than a placebo, hand-washing-plan SSI (Remain COVID Free) in ...
What is the current status of trial NCT04459455?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2020-08-19. Estimated completion is 2020-10-15.
What conditions does trial NCT04459455 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT04459455?
The interventions under investigation include: Contain COVID Anxiety SSI (BEHAVIORAL), Remain COVID Free SSI (BEHAVIORAL).
Who is sponsoring clinical trial NCT04459455?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04459455 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04459455's enrollment target sits among peer trials
500 31st of 364 higher than 329 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI